Want to see CH:KURN full AI Analyst Report?
Kuros Biosciences (KURN) Income Statement
Kuros Biosciences Income Statement
Last quarter (Q2 2026), Kuros Biosciences's total revenue was $72.67M, an increase of 128.21% from the same quarter last year. In Q2, Kuros Biosciences's net income was $3.47M. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 121.30M | $ 75.56M | $ 33.56M | $ 17.99M | $ 13.81M | |
| $ 104.79M | $ 62.03M | $ 23.94M | $ 10.77M | $ 10.07M | |
| $ 97.47M | $ 67.03M | $ 38.09M | $ 24.21M | $ 18.83M | |
| Depreciation and Amortization | $ 2.68M | $ 2.66M | $ 2.75M | $ 2.83M | $ 2.88M |
| $ 10.01M | $ -537.00K | $ -6.84M | $ -8.84M | $ -5.29M | |
| $ 7.33M | $ -5.00M | $ -13.19M | $ -13.45M | $ -8.77M | |
| $ -3.16M | $ 1.65M | $ -155.00K | $ -2.54M | $ -787.00K | |
| $ 4.16M | $ -3.35M | $ -9.78M | $ -15.99M | $ -9.55M | |
| $ 2.12M | $ -3.72M | $ -13.73M | $ -14.60M | $ -7.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.06 | $ -0.10 | $ -0.38 | $ -0.43 | $ -0.23 |
| Diluted EPS | $ 0.05 | $ -0.10 | $ -0.38 | $ -0.43 | $ -0.23 |
| Weighted Average Shares Outstanding | 38.44M | 37.20M | 36.58M | 33.90M | 32.79M |
| Weighted Average Shares Outstanding (Diluted) | 41.39M | 37.20M | 36.58M | 33.90M | 32.79M |
Currency in CHF
